1

STAAR Surgical

#5667

Rank

$889.34M

Marketcap

US United States

Country

STAAR Surgical
Leadership team

Ms. Caren L. Mason (CEO, Pres & Director)

Mr. Patrick F. Williams (Chief Financial Officer)

Dr. Keith Holliday (Chief Technology Officer)

Products/ Services
Health Care, Manufacturing, Medical Device
Number of Employees
500 - 1000
Headquarters
Monrovia, California, United States
Established
1982
Company Registration
SEC CIK number: 0000718937
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
STAA
Social Media
Overview
Location
Summary
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
History

STAAR Surgical was founded in 1985 and is headquartered in Monrovia, California. Over the years, STAAR Surgical has grown to become a global leader in the development and manufacture of implantable lenses for cataract, refractive and astigmatism correction.

Mission
STAAR designs, develops, manufactures and markets implantable lenses for the eye and companion delivery systems. These lenses are intended to provide visual freedom to patients, lessening or eliminating the reliance on glasses or contact lenses.
Vision
Evolution in Visual Freedom
Key Team

Mr. Hans-Martin Blickensdoerfer (Consultant)

Dr. Scott D. Barnes M.D. (Chief Medical Officer)

Mr. James Francese (Sr. VP of Commercial Operations - North America & APAC)

Mr. Brian Moore (VP of Investor, Media Relations & Corp. Devel.)

Mr. Samuel J. Gesten (Chief Legal Officer & Corp. Sec.)

Joanne Egamino Ph.D. (Global Head of Clinical Operations)

Mr. Philippe Subrin (VP of Collamer Lens Manufacturing & GM of Nidau Operations)

Recognition and Awards
STAAR Surgical and its products have been recognized nationally and internationally with a variety of awards and honours, including The National Institute of Health's Innovation Awards, the Asia-Pacific Association of Cataract & Refractive Surgeons Innovation Award, the American Academy of Ophthalmology Clinical Research Award, the Outstanding Research & Innovation Award in Photonics, and the EyeWorld Future Technology Award.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

STAAR Surgical
Leadership team

Ms. Caren L. Mason (CEO, Pres & Director)

Mr. Patrick F. Williams (Chief Financial Officer)

Dr. Keith Holliday (Chief Technology Officer)

Products/ Services
Health Care, Manufacturing, Medical Device
Number of Employees
500 - 1000
Headquarters
Monrovia, California, United States
Established
1982
Company Registration
SEC CIK number: 0000718937
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
STAA
Social Media